Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-02

AUTHORS

Greg Fulcher, Roopa Mehta, Edmond G. Fita, Magnus Ekelund, Stephen C. Bain

ABSTRACT

INTRODUCTION: The majority of elderly patients (≥ 65 years of age) with type 2 diabetes mellitus (T2DM) will eventually require insulin therapy, but they are particularly vulnerable to hypoglycemia and challenging to treat. Insulin degludec/insulin aspart (IDegAsp) is a novel co-formulation of 70% insulin degludec and 30% insulin aspart administered in a single injection, either once or twice daily with main meals. METHODS: A combined analysis of the phase 3 BOOST INTENSIFY PREMIX I (NCT01009580) and BOOST INTENSIFY ALL (NCT01059812) trials has previously reported lower rates of hypoglycemia during the maintenance period in patients with T2DM treated with IDegAsp twice daily (BID) versus biphasic insulin aspart 30 (BIAsp 30) BID. This post hoc analysis examined the safety and efficacy of IDegAsp versus BIAsp 30 in elderly patients from the global population of these two trials, and also from the Japanese cohort of BOOST INTENSIFY ALL. RESULTS: Change in HbA1c was similar for IDegAsp versus BIAsp 30 (p > 0.5). Compared with BIAsp 30, IDegAsp resulted in significant reductions in fasting plasma glucose (p < 0.0001), numerically lower rates of overall and nocturnal hypoglycemia (global estimated rate ratios: 0.92 [0.67; 1.26]95% confidence interval [CI], p = 0.5980 and 0.67 [0.39; 1.18]95% CI, p = 0.1676, respectively), and a significantly lower total daily insulin dose at end of trial (global estimated treatment difference 0.79 [0.73; 0.87]95% CI, p < 0.0001) in elderly patients. CONCLUSION: The results described here are consistent with those of the overall trial populations, demonstrating that IDegAsp BID is efficacious in elderly patients and suggesting that there is no need for special safety precautions. FUNDING: Novo Nordisk. TRIAL REGISTRATION: ClinicalTrials.gov identifiers, NCT01009580 and NCT01059812. Plain language summary available for this article. More... »

PAGES

107-118

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-018-0531-0

DOI

http://dx.doi.org/10.1007/s13300-018-0531-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1110176976

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30474818


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Sydney", 
          "id": "https://www.grid.ac/institutes/grid.1013.3", 
          "name": [
            "Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fulcher", 
        "givenName": "Greg", 
        "id": "sg:person.012042556624.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012042556624.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n", 
          "id": "https://www.grid.ac/institutes/grid.416850.e", 
          "name": [
            "Unidad de Investigaci\u00f3n en Enfermedades Metab\u00f3licas, Departamento de Endocrinolog\u00eda y Metabolismo, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehta", 
        "givenName": "Roopa", 
        "id": "sg:person.0647030077.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647030077.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novo Nordisk (Denmark)", 
          "id": "https://www.grid.ac/institutes/grid.425956.9", 
          "name": [
            "Novo Nordisk A/S, S\u00f8borg, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fita", 
        "givenName": "Edmond G.", 
        "id": "sg:person.010517764521.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010517764521.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novo Nordisk (Denmark)", 
          "id": "https://www.grid.ac/institutes/grid.425956.9", 
          "name": [
            "Novo Nordisk A/S, S\u00f8borg, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ekelund", 
        "givenName": "Magnus", 
        "id": "sg:person.011152254753.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011152254753.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Swansea University", 
          "id": "https://www.grid.ac/institutes/grid.4827.9", 
          "name": [
            "Diabetes Research Unit Cymru, Swansea University, ABM University Health Board, Swansea, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bain", 
        "givenName": "Stephen C.", 
        "id": "sg:person.015324426577.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015324426577.19"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00125-008-1147-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002486476", 
          "https://doi.org/10.1007/s00125-008-1147-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-008-1147-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002486476", 
          "https://doi.org/10.1007/s00125-008-1147-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-008-1147-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002486476", 
          "https://doi.org/10.1007/s00125-008-1147-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjopharm.2011.02.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006560336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-014-0070-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007300078", 
          "https://doi.org/10.1007/s13300-014-0070-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/geront/gnr067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009544742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-2329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010006143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ijcp.12821", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010928795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pcd.2016.09.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010989413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-012-0034-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013035423", 
          "https://doi.org/10.1007/s12325-012-0034-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jdiacomp.2006.02.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013221696"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2009.460", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016104743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc14-2441", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021071301"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/joim.12000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021963953"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-1205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022420361"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)60204-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023183552"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ijgm.s26889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023610248"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1753-0407.12524", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024731469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1753-0407.12524", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024731469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1532-5415.2007.01430.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025134040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-1668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027148967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2012-3249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029582685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40266-015-0272-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031506658", 
          "https://doi.org/10.1007/s40266-015-0272-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40266-015-0272-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031506658", 
          "https://doi.org/10.1007/s40266-015-0272-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/jdi.12461", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032168072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1532-5415.51.5s.1.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034396042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-016-0455-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042127363", 
          "https://doi.org/10.1007/s40262-016-0455-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-016-0455-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042127363", 
          "https://doi.org/10.1007/s40262-016-0455-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1753-0407.12355", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043853829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)60205-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045232304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc09-0097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046700854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200118010-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047233320", 
          "https://doi.org/10.2165/00002512-200118010-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200118010-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047233320", 
          "https://doi.org/10.2165/00002512-200118010-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc13-2908", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048017302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabres.2014.09.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052211300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/jdi.12102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053683331"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.14336/ad.2014.0330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067267901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18553/jmcp.2015.21.3.243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068661486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc15-0160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070730040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078990797", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0889-8529(18)30041-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082453143"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02", 
    "datePublishedReg": "2019-02-01", 
    "description": "INTRODUCTION: The majority of elderly patients (\u2265\u200965\u00a0years of age) with type 2 diabetes mellitus (T2DM) will eventually require insulin therapy, but they are particularly vulnerable to hypoglycemia and challenging to treat. Insulin degludec/insulin aspart (IDegAsp) is a novel co-formulation of 70% insulin degludec and 30% insulin aspart administered in a single injection, either once or twice daily with main meals.\nMETHODS: A combined analysis of the phase 3 BOOST INTENSIFY PREMIX I (NCT01009580) and BOOST INTENSIFY ALL (NCT01059812) trials has previously reported lower rates of hypoglycemia during the maintenance period in patients with T2DM treated with IDegAsp twice daily (BID) versus biphasic insulin aspart 30 (BIAsp 30) BID. This post hoc analysis examined the safety and efficacy of IDegAsp versus BIAsp 30 in elderly patients from the global population of these two trials, and also from the Japanese cohort of BOOST INTENSIFY ALL.\nRESULTS: Change in HbA1c was similar for IDegAsp versus BIAsp 30 (p\u2009>\u20090.5). Compared with BIAsp 30, IDegAsp resulted in significant reductions in fasting plasma glucose (p\u2009 <\u20090.0001), numerically lower rates of overall and nocturnal hypoglycemia (global estimated rate ratios: 0.92 [0.67; 1.26]95% confidence interval [CI], p\u2009 =\u20090.5980 and 0.67 [0.39; 1.18]95% CI, p \u2009=\u20090.1676, respectively), and a significantly lower total daily insulin dose at end of trial (global estimated treatment difference 0.79 [0.73; 0.87]95% CI, p \u2009<\u20090.0001) in elderly patients.\nCONCLUSION: The results described here are consistent with those of the overall trial populations, demonstrating that IDegAsp BID is efficacious in elderly patients and suggesting that there is no need for special safety precautions.\nFUNDING: Novo Nordisk.\nTRIAL REGISTRATION: ClinicalTrials.gov identifiers, NCT01009580 and NCT01059812. Plain language summary available for this article.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s13300-018-0531-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials", 
    "pagination": "107-118", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d5e4964aa2686784efc22392e6d71b8e8d42fa66f52b9274c1532ff3cb00ced0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30474818"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101539025"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-018-0531-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1110176976"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-018-0531-0", 
      "https://app.dimensions.ai/details/publication/pub.1110176976"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000338_0000000338/records_47995_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs13300-018-0531-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0531-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0531-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0531-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0531-0'


 

This table displays all metadata directly associated to this object as RDF triples.

216 TRIPLES      21 PREDICATES      64 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-018-0531-0 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nc3a2d153288d4b81ba1df0f57f0539f4
4 schema:citation sg:pub.10.1007/s00125-008-1147-0
5 sg:pub.10.1007/s12325-012-0034-8
6 sg:pub.10.1007/s13300-014-0070-2
7 sg:pub.10.1007/s40262-016-0455-7
8 sg:pub.10.1007/s40266-015-0272-y
9 sg:pub.10.2165/00002512-200118010-00003
10 https://app.dimensions.ai/details/publication/pub.1078990797
11 https://doi.org/10.1001/jama.2009.460
12 https://doi.org/10.1016/j.amjopharm.2011.02.006
13 https://doi.org/10.1016/j.diabres.2014.09.026
14 https://doi.org/10.1016/j.jdiacomp.2006.02.004
15 https://doi.org/10.1016/j.pcd.2016.09.003
16 https://doi.org/10.1016/s0140-6736(12)60204-9
17 https://doi.org/10.1016/s0140-6736(12)60205-0
18 https://doi.org/10.1016/s0889-8529(18)30041-0
19 https://doi.org/10.1046/j.1532-5415.51.5s.1.x
20 https://doi.org/10.1093/geront/gnr067
21 https://doi.org/10.1111/1753-0407.12355
22 https://doi.org/10.1111/1753-0407.12524
23 https://doi.org/10.1111/ijcp.12821
24 https://doi.org/10.1111/j.1532-5415.2007.01430.x
25 https://doi.org/10.1111/jdi.12102
26 https://doi.org/10.1111/jdi.12461
27 https://doi.org/10.1111/joim.12000
28 https://doi.org/10.1210/jc.2012-3249
29 https://doi.org/10.14336/ad.2014.0330
30 https://doi.org/10.18553/jmcp.2015.21.3.243
31 https://doi.org/10.2147/ijgm.s26889
32 https://doi.org/10.2337/dc09-0097
33 https://doi.org/10.2337/dc12-1205
34 https://doi.org/10.2337/dc12-1668
35 https://doi.org/10.2337/dc12-2329
36 https://doi.org/10.2337/dc13-2908
37 https://doi.org/10.2337/dc14-2441
38 https://doi.org/10.2337/dc15-0160
39 schema:datePublished 2019-02
40 schema:datePublishedReg 2019-02-01
41 schema:description INTRODUCTION: The majority of elderly patients (≥ 65 years of age) with type 2 diabetes mellitus (T2DM) will eventually require insulin therapy, but they are particularly vulnerable to hypoglycemia and challenging to treat. Insulin degludec/insulin aspart (IDegAsp) is a novel co-formulation of 70% insulin degludec and 30% insulin aspart administered in a single injection, either once or twice daily with main meals. METHODS: A combined analysis of the phase 3 BOOST INTENSIFY PREMIX I (NCT01009580) and BOOST INTENSIFY ALL (NCT01059812) trials has previously reported lower rates of hypoglycemia during the maintenance period in patients with T2DM treated with IDegAsp twice daily (BID) versus biphasic insulin aspart 30 (BIAsp 30) BID. This post hoc analysis examined the safety and efficacy of IDegAsp versus BIAsp 30 in elderly patients from the global population of these two trials, and also from the Japanese cohort of BOOST INTENSIFY ALL. RESULTS: Change in HbA1c was similar for IDegAsp versus BIAsp 30 (p > 0.5). Compared with BIAsp 30, IDegAsp resulted in significant reductions in fasting plasma glucose (p  < 0.0001), numerically lower rates of overall and nocturnal hypoglycemia (global estimated rate ratios: 0.92 [0.67; 1.26]95% confidence interval [CI], p  = 0.5980 and 0.67 [0.39; 1.18]95% CI, p  = 0.1676, respectively), and a significantly lower total daily insulin dose at end of trial (global estimated treatment difference 0.79 [0.73; 0.87]95% CI, p  < 0.0001) in elderly patients. CONCLUSION: The results described here are consistent with those of the overall trial populations, demonstrating that IDegAsp BID is efficacious in elderly patients and suggesting that there is no need for special safety precautions. FUNDING: Novo Nordisk. TRIAL REGISTRATION: ClinicalTrials.gov identifiers, NCT01009580 and NCT01059812. Plain language summary available for this article.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree true
45 schema:isPartOf N2ce61649a756488198f2d4fc014da873
46 Nba210f0903f0447dafa2de8f3d89f88f
47 sg:journal.1044057
48 schema:name Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials
49 schema:pagination 107-118
50 schema:productId N37ca90f93ecf4686b54a1e33605bf279
51 N68bb59290cc747c0898717eebd747ebb
52 Nb5403b0862c947baa7bb80f314d46244
53 Nc658f8589bc44adeb099a92b5b3d554e
54 Ne5e5bc527dbd42d5a7d866626ef9ec58
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110176976
56 https://doi.org/10.1007/s13300-018-0531-0
57 schema:sdDatePublished 2019-04-11T09:14
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher Nf80a214d061c48b38a5027331dbdc63c
60 schema:url https://link.springer.com/10.1007%2Fs13300-018-0531-0
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N2ce61649a756488198f2d4fc014da873 schema:volumeNumber 10
65 rdf:type schema:PublicationVolume
66 N37ca90f93ecf4686b54a1e33605bf279 schema:name pubmed_id
67 schema:value 30474818
68 rdf:type schema:PropertyValue
69 N49ca8512446d4c23b9a3db7d394f314c rdf:first sg:person.015324426577.19
70 rdf:rest rdf:nil
71 N68bb59290cc747c0898717eebd747ebb schema:name doi
72 schema:value 10.1007/s13300-018-0531-0
73 rdf:type schema:PropertyValue
74 N9e35ca9691074133b04b01a57c96266a rdf:first sg:person.0647030077.37
75 rdf:rest Nbcd5cff94871450f845a03e4c15bfa2c
76 Nb5403b0862c947baa7bb80f314d46244 schema:name nlm_unique_id
77 schema:value 101539025
78 rdf:type schema:PropertyValue
79 Nba210f0903f0447dafa2de8f3d89f88f schema:issueNumber 1
80 rdf:type schema:PublicationIssue
81 Nbcd5cff94871450f845a03e4c15bfa2c rdf:first sg:person.010517764521.38
82 rdf:rest Nddac76c83f0d4b8b87fde10baafbf913
83 Nc3a2d153288d4b81ba1df0f57f0539f4 rdf:first sg:person.012042556624.47
84 rdf:rest N9e35ca9691074133b04b01a57c96266a
85 Nc658f8589bc44adeb099a92b5b3d554e schema:name dimensions_id
86 schema:value pub.1110176976
87 rdf:type schema:PropertyValue
88 Nddac76c83f0d4b8b87fde10baafbf913 rdf:first sg:person.011152254753.12
89 rdf:rest N49ca8512446d4c23b9a3db7d394f314c
90 Ne5e5bc527dbd42d5a7d866626ef9ec58 schema:name readcube_id
91 schema:value d5e4964aa2686784efc22392e6d71b8e8d42fa66f52b9274c1532ff3cb00ced0
92 rdf:type schema:PropertyValue
93 Nf80a214d061c48b38a5027331dbdc63c schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
96 schema:name Medical and Health Sciences
97 rdf:type schema:DefinedTerm
98 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
99 schema:name Clinical Sciences
100 rdf:type schema:DefinedTerm
101 sg:journal.1044057 schema:issn 1869-6953
102 1869-6961
103 schema:name Diabetes Therapy
104 rdf:type schema:Periodical
105 sg:person.010517764521.38 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
106 schema:familyName Fita
107 schema:givenName Edmond G.
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010517764521.38
109 rdf:type schema:Person
110 sg:person.011152254753.12 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
111 schema:familyName Ekelund
112 schema:givenName Magnus
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011152254753.12
114 rdf:type schema:Person
115 sg:person.012042556624.47 schema:affiliation https://www.grid.ac/institutes/grid.1013.3
116 schema:familyName Fulcher
117 schema:givenName Greg
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012042556624.47
119 rdf:type schema:Person
120 sg:person.015324426577.19 schema:affiliation https://www.grid.ac/institutes/grid.4827.9
121 schema:familyName Bain
122 schema:givenName Stephen C.
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015324426577.19
124 rdf:type schema:Person
125 sg:person.0647030077.37 schema:affiliation https://www.grid.ac/institutes/grid.416850.e
126 schema:familyName Mehta
127 schema:givenName Roopa
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647030077.37
129 rdf:type schema:Person
130 sg:pub.10.1007/s00125-008-1147-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002486476
131 https://doi.org/10.1007/s00125-008-1147-0
132 rdf:type schema:CreativeWork
133 sg:pub.10.1007/s12325-012-0034-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013035423
134 https://doi.org/10.1007/s12325-012-0034-8
135 rdf:type schema:CreativeWork
136 sg:pub.10.1007/s13300-014-0070-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007300078
137 https://doi.org/10.1007/s13300-014-0070-2
138 rdf:type schema:CreativeWork
139 sg:pub.10.1007/s40262-016-0455-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042127363
140 https://doi.org/10.1007/s40262-016-0455-7
141 rdf:type schema:CreativeWork
142 sg:pub.10.1007/s40266-015-0272-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1031506658
143 https://doi.org/10.1007/s40266-015-0272-y
144 rdf:type schema:CreativeWork
145 sg:pub.10.2165/00002512-200118010-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047233320
146 https://doi.org/10.2165/00002512-200118010-00003
147 rdf:type schema:CreativeWork
148 https://app.dimensions.ai/details/publication/pub.1078990797 schema:CreativeWork
149 https://doi.org/10.1001/jama.2009.460 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016104743
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1016/j.amjopharm.2011.02.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006560336
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/j.diabres.2014.09.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052211300
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/j.jdiacomp.2006.02.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013221696
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/j.pcd.2016.09.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010989413
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/s0140-6736(12)60204-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023183552
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1016/s0140-6736(12)60205-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045232304
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1016/s0889-8529(18)30041-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082453143
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1046/j.1532-5415.51.5s.1.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034396042
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1093/geront/gnr067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009544742
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1111/1753-0407.12355 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043853829
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1111/1753-0407.12524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024731469
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1111/ijcp.12821 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010928795
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1111/j.1532-5415.2007.01430.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025134040
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1111/jdi.12102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053683331
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1111/jdi.12461 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032168072
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1111/joim.12000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021963953
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1210/jc.2012-3249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029582685
184 rdf:type schema:CreativeWork
185 https://doi.org/10.14336/ad.2014.0330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067267901
186 rdf:type schema:CreativeWork
187 https://doi.org/10.18553/jmcp.2015.21.3.243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068661486
188 rdf:type schema:CreativeWork
189 https://doi.org/10.2147/ijgm.s26889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023610248
190 rdf:type schema:CreativeWork
191 https://doi.org/10.2337/dc09-0097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046700854
192 rdf:type schema:CreativeWork
193 https://doi.org/10.2337/dc12-1205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022420361
194 rdf:type schema:CreativeWork
195 https://doi.org/10.2337/dc12-1668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027148967
196 rdf:type schema:CreativeWork
197 https://doi.org/10.2337/dc12-2329 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010006143
198 rdf:type schema:CreativeWork
199 https://doi.org/10.2337/dc13-2908 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048017302
200 rdf:type schema:CreativeWork
201 https://doi.org/10.2337/dc14-2441 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021071301
202 rdf:type schema:CreativeWork
203 https://doi.org/10.2337/dc15-0160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070730040
204 rdf:type schema:CreativeWork
205 https://www.grid.ac/institutes/grid.1013.3 schema:alternateName University of Sydney
206 schema:name Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia
207 rdf:type schema:Organization
208 https://www.grid.ac/institutes/grid.416850.e schema:alternateName Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
209 schema:name Unidad de Investigación en Enfermedades Metabólicas, Departamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
210 rdf:type schema:Organization
211 https://www.grid.ac/institutes/grid.425956.9 schema:alternateName Novo Nordisk (Denmark)
212 schema:name Novo Nordisk A/S, Søborg, Denmark
213 rdf:type schema:Organization
214 https://www.grid.ac/institutes/grid.4827.9 schema:alternateName Swansea University
215 schema:name Diabetes Research Unit Cymru, Swansea University, ABM University Health Board, Swansea, UK
216 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...